Clinical heterogeneity remains a major challenge across human diseases, where patients with similar genetic backgrounds frequently exhibit striking differences in disease progression, therapeutic response and clinical outcome. Increasing evidence indicates that these differences cannot be explained by genetic variation...
Shahper Nazeer Khan, Danishuddin, Salamatu Tijjani Isah et al.· Biomolecules· 0 citations
Biomedical Digital Twins (DTs) are emerging as a significant concept in precision health and drug discovery, enabling dynamic, high-resolution representations of patients through the real-time integration of multimodal datasets. While most studies focus on organ or patient-level models, accurate prediction of drug resp...
Danishuddin, M. Haque, G. Madhukar et al.· Biotechnology Advances· 0 citations
This review elucidates PRMT1’s multifaceted role in cancer biology and underscores its potential as a target for precision oncology, laying the groundwork for future therapeutic strategies.
Shahper Nazeer Khan, Aamir Ahmad, M. H. Siddiqui· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.